Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 3
2017 2
2018 3
2019 2
2020 5
2022 4
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations.
Rodriguez E, Zwart ES, Affandi AA, Verhoeff J, de Kok M, Boyd LNC, Meijer LL, Le Large TYS, Olesek K, Giovannetti E, García-Vallejo JJ, Mebius RE, van Kooyk Y, Kazemier G. Rodriguez E, et al. Among authors: meijer ll. Cancer Sci. 2024 Apr 30. doi: 10.1111/cas.16147. Online ahead of print. Cancer Sci. 2024. PMID: 38686549 Free article.
Prognostic value of microRNA-21 in intra- and extrahepatic cholangiocarcinoma after radical resection: cohort study.
Boyd LNC, Ali M, Comandatore A, Brandi G, Tavolari S, Gaeta R, Meijer LL, Le Large TYS, Riefolo M, Vasuri F, Morelli L, van Laarhoven HWM, Giovannetti E, Kazemier G, Garajová I. Boyd LNC, et al. Among authors: meijer ll. BJS Open. 2024 Mar 1;8(2):zrae031. doi: 10.1093/bjsopen/zrae031. BJS Open. 2024. PMID: 38637298 Free PMC article. No abstract available.
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease.
Mato Prado M, Puik JR, Castellano L, López-Jiménez E, Liu DSK, Meijer LL, Le Large TYS, Rees E, Funel N, Sivakumar S, Pereira SP, Kazemier G, Zonderhuis BM, Erdmann JI, Swijnenburg RJ, Frilling A, Jiao LR, Stebbing J, Giovannetti E, Krell J, Frampton AE. Mato Prado M, et al. Among authors: meijer ll. Exp Hematol Oncol. 2023 Dec 1;12(1):101. doi: 10.1186/s40164-023-00458-3. Exp Hematol Oncol. 2023. PMID: 38041102 Free PMC article.
Spatial immune composition of tumor microenvironment in patients with pancreatic cancer.
Zwart ES, van Ee T, Affandi AJ, Boyd LNC, Rodriguez E, den Haan JMM, Farina A, van Grieken NCT, Meijer LL, van Kooyk Y, Mebius RE, Kazemier G. Zwart ES, et al. Among authors: meijer ll. Cancer Immunol Immunother. 2023 Dec;72(12):4385-4397. doi: 10.1007/s00262-023-03573-6. Epub 2023 Nov 8. Cancer Immunol Immunother. 2023. PMID: 37938368 Free PMC article.
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study.
Boyd LNC, Nooijen LE, Ali M, Puik JR, Moustaquim J, Fraga Rodrigues SM, Broos R, Belkouz A, Meijer LL, Le Large TYS, Erdmann JI, Hooijer GKJ, Heger M, Van Laarhoven HWM, Roos E, Kazemier G, Giovannetti E, Verheij J, Klümpen HJ. Boyd LNC, et al. Among authors: meijer ll. Front Pharmacol. 2023 Oct 18;14:1274692. doi: 10.3389/fphar.2023.1274692. eCollection 2023. Front Pharmacol. 2023. PMID: 37920204 Free PMC article.
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers.
Boyd LNC, Ali M, Comandatore A, Garajova I, Kam L, Puik JR, Fraga Rodrigues SM, Meijer LL, Le Large TYS, Besselink MG, Morelli L, Frampton A, van Laarhoven HWM, Giovannetti E, Kazemier G. Boyd LNC, et al. Among authors: meijer ll. JAMA Netw Open. 2023 Aug 1;6(8):e2331197. doi: 10.1001/jamanetworkopen.2023.31197. JAMA Netw Open. 2023. PMID: 37639271 Free PMC article.
The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer.
Zwart ES, van Ee T, Doppenberg D, Farina A, Wilmink JW, Versteijne E, Busch OR, Besselink MG, Meijer LL, van Kooyk Y, Mebius RE, Kazemier G. Zwart ES, et al. Among authors: meijer ll. J Cancer Res Clin Oncol. 2023 Nov;149(16):14731-14743. doi: 10.1007/s00432-023-05219-7. Epub 2023 Aug 17. J Cancer Res Clin Oncol. 2023. PMID: 37587309 Free PMC article.
hENT1 as a Predictive Biomarker in PDAC-Letter.
Boyd LNC, Ali M, Puik JR, Meijer LL, Le Large TYS, van Laarhoven HWM, Giovannetti E, Kazemier G. Boyd LNC, et al. Among authors: meijer ll. Clin Cancer Res. 2023 Aug 1;29(15):2944. doi: 10.1158/1078-0432.CCR-22-3827. Clin Cancer Res. 2023. PMID: 37525961 No abstract available.
Clinical characteristics and long-term outcomes following pancreatic injury - An international multicenter cohort study.
Meijer LL, Vaalavuo Y, Regnér S, Sallinen V, Lemma A, Arnelo U, Valente R, Westermark S, An D, Moir JAG, Irwin EA, Biesel EA, Hopt UT, Fichtner-Feigl S, Wittel UA, Weniger M, Karle H, Bloemers FW, Sutton R, Charnley RM, Ruess DA, Szatmary P. Meijer LL, et al. Heliyon. 2023 Jun 21;9(6):e17436. doi: 10.1016/j.heliyon.2023.e17436. eCollection 2023 Jun. Heliyon. 2023. PMID: 37408878 Free PMC article.
Crohn's disease: preserve or resect the mesentery?
Meijer LL, Ayez N, van Kessel CS. Meijer LL, et al. Br J Surg. 2023 Oct 10;110(11):1415-1418. doi: 10.1093/bjs/znad135. Br J Surg. 2023. PMID: 37178332 No abstract available.
31 results